Involvement of integrin-linked kinase in capillary/tube-like network formation of human vascular endothelial cells by Watanabe, Motomu et al.
 
 
 
 
 
© 2005 by the author(s). This paper is Open Access and is published in Biological Procedures Online under license from the author(s). Copying, 
printing, redistribution and storage permitted.  Journal © 1997-2005 Biological Procedures Online. 
Biol. Proced. Online 2005; 7(1): 41-47. 
doi:10.1251/bpo104 
April 27, 2005 
 
Involvement of integrin-linked kinase in capillary/tube-like network 
formation of human vascular endothelial cells 
 
Motomu Watanabe1A, Yayoi Fujioka-Kaneko2, Hisayuki Kobayashi3, Mamoru Kiniwa1, Michihiko 
Kuwano4 and Yuji Basaki5*A 
 
1Advanced Research Laboratory, Taiho Pharmaceutical Co., Ltd., Saitama, 357-8527, Japan. 
 
2Drug Discovery Laboratory, Taiho Pharmaceutical Co., Ltd., Saitama, 357-8527, Japan. 
 
3Biochemical Laboratory, Nitta Gelatin Inc., Osaka, 581-0024, Japan. 
 
4Research Center for Innovative Cancer Therapy, Kurume University, Fukuoka, 830-0011, Japan, Station-II for Collaborative Research, Kyushu University, 
Fukuoka, 812-8582, Japan. 
 
5Advanced Research Laboratory, Taiho Pharmaceutical Co., Ltd., Saitama, 357-8527, Japan, and Station-II for Collaborative Research, Jyushu University, 
Fukuoka, 812-8582, Japan, and Department of Medical Biochemistry, Graduate School of Medical Science, Kyushu University. Fukuoka, 812-8582. Japan. 
 
AWatanabe and Basaki contributed equally to this manuscript. 
 
*Corresponding Author: Yuji Basaki, Ph.D., Department of Medical Biochemistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi 
Higashi-ku, Fukuoka, 812-8582, Japan. Phone/Fax: 81-92-642-6295, Email: yubasaki@yahoo.co.jp 
 
Submitted: December 16, 2004; Revised: March 16, 2005; Accepted: March 28, 2005. 
 
Indexing terms: Endothelial Cells; Vascular Endothelial Growth Factor A; Integrin-Linked Kinase. 
 
Abbreviations: ECM, extracellular matrix; HUVEC, human umbilical vein endothelial cells; ILK, integrin-linked kinase; KD, kinase deficient; PI 3-kinase, 
phosphatidylinositol 3-kinase; PKB, protein kinase B; VEGF, vascular endothelial growth factor. 
 
 
 
ABSTRACT 
 
Angiogenesis is a complex process involving an ECM and vascular endothelial cells (EC), and is regulated by various 
angiogenic factors including VEGF. The ability to form a capillary/tube-like network is a specialized function of EC. 
Therefore, in vitro angiogenesis was assessed by a capillary/tube-like network formation assay. There are three 
angiogenic parameters: capillary length, number of capillaries, and relative capillary area per field. We evaluated 
capillary length per field in the assay. VEGF promoted capillary/tube-like network formation of EC in a type I collagen 
gel matrix in vitro. Moreover, we demonstrated the involvement of ILK in a VEGF signaling pathway mediating 
capillary/tube-like network formation of EC using dominant-negative, kinase deficient ILK. This is a straightforward 
assay to monitor responses of human vascular endothelial cells. 
 
 
INTRODUCTION 
 
Angiogenesis, the formation of new blood vessels from 
pre-existing ones, is a critical factor in many diseases, 
such as diabetic retinopathy, rheumatoid arthritis, and 
tumor progression (1). On the other hand, 
neovascularisation during embryonic development is 
distinguished from angiogenesis. Angiogenesis is a 
complex process involving extracellular matrix (ECM)  
and vascular endothelial cells, and is regulated by 
various angiogenic factors including vascular endothelial  
 
 
growth factor (VEGF), fibroblast growth factor-2 (FGF-2), 
interleukin-8 (IL-8), transforming growth factor-α (TGF- 
α), and others (2, 3). These factors can promote cell 
proliferation, chemotactic migration, and capillary/tube-
like network formation of vascular endothelial cells in 
vitro and in vivo. The endothelial-specific mitogen VEGF 
has been shown to be a key positive regulator of tumor 
angiogenesis including glioblastoma, colon, breast, renal, 
and other tumors (4-6). The ability to form a 
capillary/tube-like network is a specialized function of 
vascular endothelial cells. VEGF also promoted     
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formation of a capillary-like network of vascular 
endothelial cells in various matrix gels such as collagen 
and fibronectin in vitro. The response of vascular 
endothelial cells to soluble angiogenic factors, as well as 
interactions between ECM and the cells were required 
for new blood vessel formation. 
 
Integrin adhesion receptors are αβ heterodimeric 
transmembrane glycoproteins that interact with the ECM 
and cytoplasmic molecules including cytoskeletal and 
catalytic signaling molecules (7-9). The integrin-linked 
kinase (ILK) is a serine/threonine protein kinase that was 
initially identified as the integrin β1-tail-binding protein 
(10). The C-terminal region of ILK exhibits significant 
homology to other protein kinase catalytic domains and 
ILK can phosphorylate protein substrates such as 
integrin  β1 cytoplasmic region, Akt/protein kinase B 
(PKB), and glycogen synthase kinase-3 (GSK-3) (11, 12). 
It has been reported that integrins cooperate with the 
VEGF receptors to promote activation of an in vitro 
angiogenic program in vascular endothelial cells (13). 
Furthermore, ILK transduces signals affecting anti-
apoptosis and cell cycle progression, and these are 
mediated by interactions between integrins and the ECM 
(14, 15). However, so far no biological function of ILK in 
vascular endothelial cells has been demonstrated. 
 
In this study, we investigate the effect of dominant-
negative, kinase deficient ILK (ILK-KD) in the 
capillary/tube-like network formation of human 
umbilical vein endothelial cells (HUVEC). We 
demonstrate a critical role for ILK in network formation 
by vascular endothelial cells in a collagen gel matrix. 
 
MATERIALS AND METHODS 
 
Cell culture and reagents 
 
Human umbilical vein endothelial cells (HUVEC) were 
obtained from Cell Systems (Kirkland, WA) and were 
cultured in collagen-coated flasks (Becton, Dickinson and 
Company, Franklin Lakes, NJ) in CS-C medium 
supplemented with 10% (v/v) heat-inactivated fetal 
bovine serum (FBS), according to the instructions of the 
supplier. Cells were passaged at 37°C in an atmosphere 
of 5% CO2. The cells from passage 3-7 were used for 
capillary/tube-like network formation assay on type I 
collagen gel matrix. RPMI-1640 medium was obtained 
from Sigma (St Louis, MO). Recombinant human 
vascular endothelial growth factor (rhVEGF) was 
purchased from R & D Systems (Minneapolis, MN). Type 
I collagen gel matrix (Cellmatrix type I-A) was from 
Nitta Gelatin Inc. (Osaka, Japan). LY294002, a selective PI 
3-kinase inhibitor, was obtained from Calbiochem (San 
Diego, CA). 
 
Plasmid constructions 
 
We used a basic procedure. Briefly, extraction of 
cytoplasmic RNA from HUVEC was performed using 
TRIzol solution (Life Technologies Inc., Grand Island, 
NY). The reverse transcription of RNA was performed in 
a reaction mixture containing total RNA, AMV reverse 
transcriptase (Promega, Madison, WI), oligo(dT)15, 
ribonuclease inhibitor, and each dNTP mixture. The 
mixture was incubated at 42°C for 30 minutes, heated to 
95°C for 5 minutes, and then chilled at 4°C for 5 minutes. 
First strand cDNA (corresponding to 1 µg of total RNA) 
was subjected to amplification using the forward primer 
5ʹ- GAG ACC CAA GCT TCT GGA TGG ACC TGG 
AAG CCT -3ʹ, the reverse primer 5ʹ- GAT GAC GCG 
GCC GCT CAG GTG CCT TTG CTT TCT G -3ʹ and high 
fidelity pfu DNA polymerase (Promega). After an initial 
cycle of denaturation at 95°C for 1 minute, polymerase 
chain reaction was carried out for 25 cycles with the 
following cycle conditions: 95°C, 30 seconds; 55°C, 30 
seconds; 72°C, 3 minutes with a postincubation of 72°C 
for 5 minutes. The PCR product was cloned into 
pcDNA3.1 (Invitrogen, Carlsbad, CA). The insert of 
recombinant plasmid, pcDNA3-ILK, was verified by 
restriction endonuclease digestion and DNA sequence 
analysis using ABI PRISM 310 Genetic Analyzer 
(Applied Biosystems, Foster City, CA). 
 
Site-directed mutagenesis 
 
Point mutation was generated into pcDNA3-ILK using 
GeneEditor in vitro Site-Directed Mutagenesis System 
(Promega), according to the manufacturer’s instructions. 
Mutant oligonucleotide (with the altered nucleotide 
underlined) was used to change glutamic acid at position 
359 to a lysine (E359K, 5’ - TGG GTA GCC CCC AAA 
GCT CTG CAG AAG - 3’) within the kinase domain (16). 
The sequences of the mutant plasmid (pcDNA3-ILK-KD) 
were confirmed by DNA sequencing. Transient 
transfections were performed with FuGENE6 
Transfection Reagent (Roche Diagnostics, GmbH,     
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Germany) 18 hours prior to VEGF stimulation, according 
to the manufacturer’s instructions. 
 
In vitro capillary/tube-like network formation assay 
on type I collagen gel matrix 
 
Endothelial capillary/tube-like network formation was 
assessed using type I collagen gel matrix. Eight volumes 
of 0.3% Cellmatrix type I-A solution (Nitta Gelatin, Inc.) 
were mixed with one volume each of reconstituted buffer 
(4.77 g Hepes and 2.2 g NaHCO3 in 100 ml of 0.05N 
NaOH) and RPMI-1640 and kept on ice. Then 150 µl 
aliquots of this reconstituted collagen solution were 
p l a c e d  i n  e a c h  w e l l  o f  48-well culture plates and 
immediately incubated at 37°C for 1 hour to allow gel 
formation. After the gel solidified, HUVEC (1.5 × 104 
cells/0.3 ml) were added to well and incubated at 37°C 
for eight hours. Subsequently, each well was washed in 
PBS, fixed with 0.5 ml of 100% methanol for 20 minutes, 
and stained with Giemsa’s solution (Merck, Darmstadt, 
Germany) at room temperature for 30 minutes. The 
formation of the capillary/tube-like networks were 
examined by using a phase-contrast microscope 
equipped with a Sony CCD video camera and evaluated 
by KS400 imaging system, release 2.0 (Carl Zeiss, 
Oberkocken, Germany). Once determined, the images 
were captured and exported to Photoshop (Adobe) or 
PowerPoint (Microsoft) for high-quality printing. All 
experiments were repeated at least twice. Results are 
presented as the means ± SD of eight fields derived from 
two wells. 
 
ILK kinase assay 
 
HUVEC stimulated with 30 ng/ml of rhVEGF for 5 
minutes were lysed in a lysis buffer. The lysates were 
precleaned with protein A-sepharose, and then 
incubated with anti-ILK antibody (Upstate 
Biotechnology, Inc., Lake Placid, NY) at 4°C for 12 hours. 
After incubation, immune complexes were collected with 
protein A-sepharose. The immunoprecipitated ILK was 
incubated with for 30 minutes at 30°C in a total volume 
of 50 µl of kinase reaction buffer (20 mM Hepes, pH7.0, 
10 mM MgCl2, 10 mM MnCl2, 2 mM NaF, 1 mM Na3VO4, 
100 µM ATP) in myelin basic protein (MBP)-coated 96-
well plate. Phosphorylation of MBP was detected using 
anti-phospho-ser/thr (Upstate Biotechnology Inc.), 
secondary antibody coupled to horseradish peroxidase 
and chemiluminescent substrate (PIERCE, Rockford, IL). 
Chemiluminescences were measured using WALLAC 
1420 Multilabel Counter. Results are presented as mean ± 
SD of four wells. 
 
Proliferation assay 
 
Aliquots of medium containing 4.0 × 103 cells were 
seeded into a collagen-coated 96-well plate. The 
following day, the medium were replaced with serum-
free CS-C medium with or without rhVEGF. The plate 
was then incubated for 48 hours before adding of WST-8 
(2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-
disulfophenyl)-2H-tetrazolium, monosodium salt (Wako 
Pure Chemical Industries Ltd., Osaka, Japan). The plates 
were read at a wavelength of 450 nm using a TECAN 
Spectra Thermo (Tecan Group Ltd. Raleigh, NC). Results 
are presented as the mean ± SD of four wells. 
 
Statistical analysis 
 
All results are expressed as the mean ± SD values. The 
statistical significance was evaluated by using the paired 
two-tailed Student’s t test. A p-value of less than 0.05 
was considered to indicate a statistically significant 
difference. Statistical analysis was performed using JMP 
5.01 software (SAS Institute Inc. Cary, NC). 
 
RESULTS AND DISCUSSION 
 
Formation of a capillary/tube-like network is induced 
by VEGF in human vascular endothelial cells 
 
In vitro angiogenesis of human vascular endothelial cells 
was assessed using a capillary/tube-like network 
formation assay. 
 
Fig. 1: Formation of a capillary/tube-like network of human vascular 
endothelial cells stimulated with VEGF. HUVEC were stimulated with 30 
ng/ml of VEGF and cultured in a type I collagen gel-coated plate for eight 
hours at 37°C. The microscopic image was recorded by a CCD video 
camera and analyzed using image analysis software. a: Microscope 
image, b: Processed image. 
 
HUVEC that were seeded onto a type I collagen gel 
matrix in RPMI-1640 medium with 30 ng/ml VEGF 
displayed formation of capillary/tube-like networks after 
eight hours of incubation at 37°C (Fig. 1A). Images were     
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taken using a phase-contrast microscope equipped with 
a CCD video camera and were evaluated by the imaging 
system. Figure 1B shows a processed image of capillary 
networks of VEGF-treated HUVEC. Three angiogenic 
parameters: capillary length per field, number of 
capillaries per field, and relative capillary area per field, 
were considered as measures of in vitro capillary/tube-
like network formation for assay development. In this 
study, we used capillary length per field for evaluation 
of angiogenesis activity. Figure 2 clearly shows that 
VEGF induced a concentration-dependent (10-100 ng/ml) 
formation of capillary/tube-like networks of HUVEC. It 
has also been demonstrated that VEGF induces network 
formation of HUVEC when reconstituted basement 
membrane matrigel (Beckton, Dickinson and Company) 
was used instead of a type I collagen gel matrix (16). The 
matrigel is a basement membrane-like matrix produced 
by the Engelbreth-Holm-Swarm (EHS) tumor, and it 
contains laminin-1, entactin, and type IV collagen (17, 
18). This result indicates that the ability of human 
vascular endothelial cells to form a capillary/tube-like 
network in response to VEGF stimulation may not 
dependent on the type of matrix. 
 
 
Fig. 2: VEGF induced capillary/tube-like network formation of human 
vascular endothelial cells in a concentration-dependent fashion. HUVEC 
(1.5 × 104 cells/well) were incubated in a type I collagen gel-coated plate 
with the indicated concentration of VEGF at 37°C for eight hours. The 
microscopic image was recorded by a CCD video camera and analyzed 
using image analysis software. The results represent the mean ± SD 
values. 
Regression of capillary/tube-like network formation 
by ILK inhibition using a dominant negative ILK 
 
Recent studies have demonstrated that cellular responses 
to various growth factors, including VEGF and platelet-
derived growth factor (PDGF), are modulated by the 
activation of integrin adhesion receptors. Furthermore, 
the cytoplasmic regions of integrins associate with 
catalytic signaling molecules such as ILK and focal 
adhesion kinase (FAK). Our next experiment was 
designated to evaluate whether VEGF-induced formation 
of capillary/tube-like networks in a type I collagen gel 
matrix was mediated by ILK. A potent dominant 
negative, kinase-deficient form of ILK (ILK-KD) contains 
a point mutation substituting a lysine for the glutamic 
acid at position 359 in the kinase domain (19). As shown 
Figure 3, ILK-KD could inhibit ILK kinase activity as a 
dominant negative. The N-terminal region of ILK 
contains a pleckstrin homology (PH)-like domain that 
probably binds a phosphatidylinositol-3, 4, 5-
triphosphate, which is a lipid product of 
phosphatidylinositol 3-kinase (PI 3-kinase). This domain 
is likely to participate in the regulation of ILK kinase 
activity (20). A selective inhibitor of PI 3-kinase, 
LY294002, also inhibited kinase activity of ILK (Fig. 3).  
 
 
Fig. 3: Inhibition of ILK kinase activity by ILK-KD or LY294002 in HUVEC. 
The cells were stimulated with 30 ng/ml VEGF for 5 minutes, and then ILK 
activity was measured by ILK kinase assay. Anti-ILK blot was prepared 
from the same immunoprecipitates used for the kinase assay (top panel). 
Bars represent the mean ± SD values. EV, empty vector; KD, ILK-KD. 
 
The VEGF-triggered capillary/tube-like network 
formation was inhibited by transfection with a vector 
encoding ILK-KD (Fig. 4).     
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Fig. 4: Effect of a dominant negative, kinase-deficient ILK on VEGF-
induced capillary/tube-like network formation of human vascular 
endothelial cells. HUVEC were transiently transfected with the indicated 
plasmids (0.5 µg/ml) 18 hours prior to VEGF stimulation. The cells were 
incubated in a type I collagen-coated plate for eight hours at 37°C with or 
without 30 ng/ml VEGF. Bars indicate as the mean ± SD values. The 
statistical significance is given for the difference between the empty 
vector-transfected groups plus and minus VEGF stimulation, and for the 
difference between VEGF-stimulated cells transfected with an empty 
vector or with a vector encoding ILK-KD, respectively. EV; empty vector, 
KD; ILK-KD. 
 
Moreover, LY294002 also suppressed capillary/tube-like 
network formation of HUVEC stimulated with VEGF 
through inhibition of ILK kinase (Fig. 5). 
 
 
Fig. 5: Effect of a LY294002 on VEGF-induced capillary/tube-like network 
formation of human vascular endothelial cells. LY294002 was added 30 
minutes before VEGF stimulation. The cells were incubated in a type I 
collagen-coated plate for eight hours at 37°C with or without 30 ng/ml 
VEGF. Bars indicate as the mean ± SD values. 
Since it has been demonstrated that VEGF is an inducer 
for proliferation of vascular endothelial cells (21), and we 
next examined the effect on ILK-KD on HUVEC 
proliferation induced by VEGF. The cells were cultured 
in the absence or presence of 30 ng/ml VEGF for 48 
hours, and then viable cells were measured by WST 
assay. Transfection of ILK-KD partially inhibited VEGF-
stimulated proliferation of HUVEC (Fig. 6). 
 
 
F i g .  6 :  E f f e c t  o f  I L K - K D  o n  H U V E C  proliferation stimulated with VEGF. 
HUVEC were transiently transfected with the indicated vectors and 
incubated for 18 hours. The cells were cultured in the absence or 
presence of VEGF for 48 hours. Viable cells were measured by WST assay. 
The results represent the mean ± SD values. 
 
Our data indicated that ILK and PI 3-kinase are involved 
in VEGF signaling pathways mediating capillary/tube-
like network formation of human vascular endothelial 
cells. 
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PROTOCOLS 
 
Protocol 1: Cell culture 
 
•  Culture human umbilical vein endothelial cells (HUVEC) in collagen-coated flasks in CS-C medium supplement 
with 10% FBS.  
•  For capillary/tube-like structure formation assay, use RPMI-1640 instead of CS-C medium. 
 
Protocol 2: Reconstitution of type I collagen gel solution 
 
•  Place a sterile tube on ice.  
•  Add eight volumes of 0.3% cold Cellmatrix type I-A solution to the tube. 
•  Add one volume of reconstitution buffer (4.77 g Hepes and 2.2 g NaHCO3 in 100 ml of 0.05N NaOH) dropwise 
while swirling the tube. Do not shake vigorously. 
•  Add one volume of cold medium and mix well. For serum-supplemented culture, routinely add one volume of 
cold FBS. 
 
Protocol 3: Formation of a type I collagen gel layer 
 
•  Transfer 150 µl cold reconstituted type I collagen gel solution into each well of 48-well culture plates. Use a pipette 
with a wide mouth since the collagen solution is viscous. 
•  Place the plate in a 37°C humidified 5% CO2 incubator and wait for 1 hour to allow gel formation. 
 
Protocol 4: Capillary/tube-like network formation assay 
 
•  Collect human umbilical vein endothelial cells. 
•  Suspend the pelleted cells in medium and wash twice. 
•  Plate the cells (300 µl of suspended cells with or without angiogenic factor) on type I collagen gel layer in each 
well. 
•  Incubate at 37 °C for 8 hours. 
•  Remove medium and wash with PBS twice. 
•  Fix with 0.5 ml of methanol and incubate for 20 minutes at room temperature.  
•  After removal of the methanol, stain the cells with Giemsa’s solution (1:20) and left to incubate at room 
temperature for 30 minutes.  
•  Wash the dishes twice with H2O. 
•  Record the microscope images with a CCD video camera and analyzed with an image analysis software. 
•  After analysis, capture the images and export to Photoshop (Adobe) or PowerPoint (Microsoft) for high-quality 
printing. 
 